<PAGE> 1
EXHIBIT 23(a)
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration
Statement on Form S-3 of King Pharmaceuticals, Inc. of our report dated February
25, 2000 (except for the information in Note 17 for which the date is June 21,
2000 and the information in Note 21(a) for which the date is March 17, 2000 and
the information in Note 21(b) for which the date is August 31, 2000) relating to
the supplementary consolidated financial statements appearing in the Company's
Form 8-K.
PricewaterhouseCoopers LLP
Atlanta, Georgia
October 19, 2000
